Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 74 (RPL21P74)
- Target
- RPL21P74
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L21 pseudogene 74 (RPL21P74) is one of the many processed pseudogenes in the human genome derived from the gene encoding ribosomal protein L21. Pseudogenes like RPL21P74 do not produce functional proteins and are generally regarded as evolutionary relics of former gene duplications or retrotransposition events[3][8]. They do not have an established biological function or disease association, nor are they recognized as potential drug targets in pharmacology. Functional ribosomal protein L21 is a component of the 60S ribosomal subunit and participates in cellular protein synthesis, but the pseudogene itself is nonfunctional[5][7][3].
- Other names
- RPL21_30_821RPL21P74
02
Mechanism of action
None (not a protein, enzyme, or regulatory RNA)
03
Biological functions
None (pseudogene; does not encode a functional product)
04
Disease associations
None directly associated
05
Safety considerations
None known (not a functional gene product or target)
06
Interacting drugs
None (no drugs have been described to target or interact with this pseudogene)
07
Biomarkers
None (not known to be used as a biomarker)
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 74 (RPL21P74).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 74 (RPL21P74).